Clinical trial · Observational
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Novel Pleural Effusion Biomarkers Screening and Evaluation in Lung Adenocarcinoma Patients
NCT07012759CI-TRIAL-00104751recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Biomarkers | — | UNRESOLVED | — |
| Lung Adenocarcinoma | Lung Adenocarcinoma | ONTOLOGY_EXACT | 0.98 |
| Pleural Effusion | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| biomarkers | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Case group
- description
- Patients with pleural effusion diagnosed as lung adenocarcinoma.
- interventionNames
- Other: biomarkers
- label
- Control group
- description
- Patients with pleural effusion diagnosed as non-malignant.
- interventionNames
- Other: biomarkers
Primary outcomes (1)
- measure
- target gene expression levels between malignant and non-malignant pleural effusions
- timeFrame
- 20 minutes
- description
- Novel biomarkers specifically expressed in malignant pleural effusions may provide additional diagnostic options for malignant lung cancer in clinical diagnosis
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients requiring thoracentesis for pleural effusion drainage as determined by a physician based on clinical need. * Signed informed consent. Exclusion Criteria: * Patients under the age of 18. * Patients with malignancies other than lung adenocarcinoma.
References
Publications (0)
Data not yet available
No reference posted for this study.